TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes in HOMA index value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in intake frequency on the six food groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in ratios of concentration on urinary nutritional biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Titers of Eosinophil Cationic Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Titers of Tumor Necrosis Factor-alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Titers of Anti-BP180-NC18A IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RBC deformability index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sensitivity and specificity of SMF method and Xpert MTB/RIF assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent with SpO2 values > 90 and < 95%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent of subjects with 1st IMA ≤9º or reduction of more than 7º
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicity of induction chemotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Response evaluation by CT scan in target lesion of HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: FVC in liters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FEV1 in liters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MVV in liters/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FEV1/FVC in percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants Prescribed All 3 Groups of Recommended Evidence-based Medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tollner score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematological scoring system (HSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dorsiflexion at the beginning of a step
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dorsiflexion in the middle of the oscillating phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline spatiotemporal gait variable
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline FMA-LE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pattern of Circulating Tumor Cells (CTCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Increase of PaCO2 more than 5mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Development and degree of any skin reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: percentage of matured oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Timing compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intracranial Clinical Benefit Rate (Cohort 1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intracranial Clinical Benefit Rate (Cohort 2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of Visceral Fat Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in sagittal abdominal diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change from Baseline in Heart Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Change from Baseline in Respiratory Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean Change from Baseline in Neural Activity within the Emotion Network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: angiographic in-stent late loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prepulse Inhibition of the Startle Response (PPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P300 Event Related Potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mismatch negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phototoxic reaction
Endpoint domain: Adverse events/effects
Primary endpoint: return of shoulder motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: resolution of adhesive capsulitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Production Rate (PR) of Low Density Lipoprotein (LDL) apoB100
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fractional Catabolic Rate (FCR) of Low Density Lipoprotein (LDL) apoB100
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Flow mediated dilatation of the brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of APD791
Endpoint domain: Adverse events/effects
Primary endpoint: Montgomery-Åsberg Depression Rating Scale (MADRS) Pre-Post Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Yale-Brown Obsessive Compulsive Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NIPPV adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Randomization in Montgomery and Asberg Depression Rating Scale (MADRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of all intended neoadjuvant therapy and surgical therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: intracranial progression free survival (IPFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in insulin sensitivity (M value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peripheral blood markers correlation with ultrasound findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound depth of the tongue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of glottic visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Genant-modified Total Sharp Score (mTSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of Margin Negative Surgical Resection (R0 Resection Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Measurement of optical aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in myocardial blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cut-off value for maximum upslope ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in coronary artery plaque volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: qualified rate of knee joint activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of patients with detectable NVP plasma level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Brain Response to Food Cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Risk of rebound during therapeutic escalations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Adverse Events reported
Endpoint domain: Adverse events/effects
Primary endpoint: Virological Response 4 Weeks After Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sustained Virological Response 24 Weeks (SVR24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Composite end-point of death, constriction, or cardiac tamponade requiring pericardial drainage
Endpoint domain: Mortality/survival
Primary endpoint: Time to Achieve Therapeutic Tacrolimus Drug Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maintain Stable Therapeutic Trough Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve of simvastatin and simvastatin acid in plasma (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration of simvastatin and simvastatin acid in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drainage volume after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal staining score change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 25OH Vitamin D level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline to Day 13 in Weighted Mean Plasma Glucose Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Average NRS
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in Worst NRS
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Number of Participants With Corneal Staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Soluble IL-2 Receptor level in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in HTLV-I viral load in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in T cell population in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in cerebrospinal fluid examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Depots of functional brown adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Men With Treatment-emergent Dizziness
Endpoint domain: Adverse events/effects
Primary endpoint: SLN Positivity Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of individuals filling a prescription for DAAs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Attention and Memory Neuropsychological Battery (NEUROPSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pancreatitis-events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change From Baseline in Hgb Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Overall Amounts of Pain Medications Consumed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Drug Use Disorders Identification Test-Consumption (DUDIT-C)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients admitted to Intensive Care Unit (ICU)
Endpoint domain: Mortality/survival
Primary endpoint: Adherence to colorectal cancer screening
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Clinical scoring of the skin reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patients Who Improved Their Condition or Did Not Worsen it
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Abdominal and femoral fat mass accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Height and weight measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fertility evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of Participants With Influenza or Influenza-like Illness (ILIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Electrocardiographic assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Asthma Patients Number
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Asthma-related Cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cmax,ss (Maximum concentration at steady state)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCτ,ss (Area under the concentration-time curve at steady state)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Continuous Glucose Monitor
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of Continuous Glucose Monitor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with myocardial inflammation (myocarditis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urinary 8-OHdG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary 8-isoprostane concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Predictability of pulse pressure variation (PPV) on fluid responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: EPIC questionnaire score on urinary domain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EPIC questionnaire score on bowel domain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sexual functioning score on IIEF-5 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Change From Baseline in SANDE Scores for Frequency and Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Cornea Vital Staining With Fluorescein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change-from-baseline intact FGF-23 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with [F-18]-DCFPyL-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Extent of baseline disease on [F-18]-DCFPyL imaging compared to conventional imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants That Selected a Particular Type of Hearing Aid
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Safety and tolerability of M2ES injection
Endpoint domain: Adverse events/effects
Primary endpoint: Time to resolution of delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of change of time to positivity (TTP) in liquid culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Spinal Cord Independence Measure III
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to Healing of Genital Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Fidelity to the model for each evidence-based practice
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient satisfaction with each evidence-based practice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Kidney Injury as Assessed by a 1.5 fold increase in a Biomarker Panel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Endotoxin activity level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroprotection rate (A/H1N1, A/H3N2, B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rate (A/H1N1, A/H3N2, B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMT fold change (A/H1N1, A/H3N2, B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Difference of Systolic Daytime Ambulatory Blood Pressure Between Summer and Winter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Difference of Diastolic Daytime Ambulatory Blood Pressure Between Summer and Winter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Difference of Systolic Night-time Ambulatory Blood Pressure Between Summer and Winter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Difference of Diastolic Night-time Ambulatory Blood Pressure Between Summer and Winter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Deliberate Self Harm Inventory
Endpoint domain: Adverse events/effects
Primary endpoint: Hip Disability and Osteoarthritis Outcome Score (HOOS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Veterans Rand 12 (VR-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EuroQol 5 dimension (EQ-5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Writing of advance directives
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Efficacy of colon cleansing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in median progression-free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Change from Baseline of the ADCS Preclinical Alzheimer Cognitive Composite (ADCS-PACC)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Oswestry Disability Index (ODI) Reduction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: myeloid toxicity prediction
Endpoint domain: Adverse events/effects
Primary endpoint: Number of adverse events (AEs), including serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: lower levels of intimate partner violence
Endpoint domain: Adverse events/effects
Primary endpoint: Immune responses to influenza vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Modified Fitzpatrick Wrinkle Severity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Macrosomia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety of Autologous Stem Cell Infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Trichotillomania Severity and Impairment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: duration of intensive care unit (ICU) stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intraoperative fluid overload (IVF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Molecular marker test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monitoring disease status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance to anti-PD-1 blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of NKG7 mRNA in CD8+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Complete clinical cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colo Rectal Functional Outcome Score (COREFO)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: change in response rate of gemcitabine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline of Systolic Ejection Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline of Fractional Shortening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of enteric neurons per ganglion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean Change in CAARS-O:SV ADHD Symptoms Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean weekly maximum composite VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual Protein Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Pcv-aCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colorectal cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes